BioCryst Pharmaceuticals BCRX Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's change in inventories?
- BioCryst Pharmaceuticals (BCRX) reported change in inventories of $4.85M in Q1 2026.
- How has BioCryst Pharmaceuticals's change in inventories changed year-over-year?
- BioCryst Pharmaceuticals's change in inventories increased by 457.1% year-over-year, from $870K to $4.85M.
- What is the long-term trend for BioCryst Pharmaceuticals's change in inventories?
- Over 2 years (2021 to 2025), BioCryst Pharmaceuticals's change in inventories has grown at a -56.8% compound annual growth rate (CAGR), from $8.77M to $1.64M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.